Associations of epicardial fat with coronary calcification, insulin resistance, inflammation, and fibroblast growth factor-23 in stage 3-5 chronic kidney disease

Table 2 Correlations with epicardial fat volume (N = 94)

Variable	r	P
Age	0.06	0.60
Body Mass Index	0.53	<0.0001
eGFR	−0.18	0.09
log UACR (N = 88)	0.30	0.004
Systolic Blood Pressure (N = 93)	0.07	0.50
Diastolic Blood Pressure (N = 93)	−0.06	0.60
log Coronary artery calcification score	0.28	0.006
Abdominal obesity	0.51	<0.0001
Log HOMA-IR (N = 72)	0.38	0.001
Fasting glucose	0.23	0.02
Triglycerides (N = 93)	0.34	0.001
LDL cholesterol (N = 92)	−0.17	0.11
HDL cholesterol (N = 93)	−0.39	<0.0001
Log hsCRP (N = 93)	0.30	0.003
Log Interleukin - 6	0.34	0.001
Log FGF-23	0.23	0.03
Phosphorus	0.08	0.50
Albumin	−0.28	0.007
25-Hydroxy Vitamin D	−0.14	0.17
1,25-Dihydroxyvitamin D	−0.13	0.23
Fetuin-A (N = 93)	−0.13	0.20
Osteoprotegerin	0.03	0.80

eGFR = estimated glomerular filtration rate; UACR = urinary albumin to creatinine ratio; HOMA-IR = homeostasis model assessment of insulin resistance; HDL = high density lipoprotein; LDL = low density lipoprotein; hsCRP = high sensitivity C-reactive protein.
FGF-23 = fibroblast growth factor −23.

ISSN: 1471-2369